Science
Clinical trials consistently show cannabis holds ‘promising potential’ for pain, says report
Pain is the most common indication to be studied in cannabinoid clinical trials since 2010, says an upcoming report.
4 results for “inflammatory-bowel-disease”
Pain is the most common indication to be studied in cannabinoid clinical trials since 2010, says an upcoming report.
CBG may be a potent therapeutic compound when it comes to inflammatory bowel disease (IBD).
Although the study highlighted that a large percentage did not discuss their usage with their doctor or specialist.
The inhalation of cannabis has been associated with clinical improvements and increased quality of life in patients with mild to moderate ulcerative colitis (UC). In a randomised, placebo-controlled trial, researchers […]